Inozyme Pharma Inc. (INZY)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
1.41
-0.11 (-7.24%)
At close: Jan 29, 2025, 3:59 PM
1.42
0.71%
After-hours Jan 29, 2025, 07:55 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
Cash & Equivalents | 34.59M | 32.91M | 23.32M | 159.90M | 31.61M | 35.97M |
Short-Term Investments | 154.00M | 94.95M | 88.48M | 119.66M | 15.53M | 7.20M |
Long-Term Investments | n/a | 354.00K | 354.00K | 12.20M | 130.00K | n/a |
Other Long-Term Assets | 2.00M | 3.81M | 3.41M | 3.54M | 56.00K | 34.00K |
Receivables | 385.00K | 115.00K | 62.00K | 155.00K | 104.00K | 31.00K |
Inventory | n/a | -115.00K | -62.00K | -12.35M | n/a | n/a |
Other Current Assets | 7.28M | 3.41M | 3.48M | 3.12M | 190.00K | 73.00K |
Total Current Assets | 196.25M | 131.39M | 115.34M | 150.98M | 47.46M | 43.27M |
Property-Plant & Equipment | 2.59M | 3.64M | 4.44M | 2.65M | 298.00K | 242.00K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 4.60M | 7.80M | 8.20M | 18.38M | 484.00K | 276.00K |
Total Assets | 200.85M | 139.19M | 123.54M | 169.36M | 47.94M | 43.54M |
Account Payables | 1.17M | 2.54M | 2.39M | 3.07M | 901.00K | 984.00K |
Deferred Revenue | n/a | 3.81M | n/a | 279.00K | n/a | n/a |
Short-Term Debt | 910.00K | 1.63M | 1.46M | n/a | n/a | n/a |
Other Current Liabilities | 12.61M | 10.54M | 7.78M | 6.90M | 2.33M | 1.41M |
Total Current Liabilities | 14.69M | 14.71M | 11.63M | 9.97M | 3.24M | 2.39M |
Long-Term Debt | 45.68M | 5.96M | 2.64M | 1.29M | n/a | n/a |
Other Long-Term Liabilities | n/a | 124.00K | n/a | n/a | n/a | 55.03M |
Total Long-Term Liabilities | 45.68M | 6.09M | 2.64M | 1.29M | 77.93M | 55.03M |
Total Liabilities | 60.37M | 20.80M | 14.27M | 11.26M | 81.16M | 57.42M |
Total Debt | 46.59M | 6.78M | 3.37M | 1.29M | n/a | n/a |
Common Stock | 6.00K | 4.00K | 2.00K | 2.00K | 1K | 1K |
Retained Earnings | -285.93M | -214.76M | -147.70M | -91.08M | -34.65M | -14.93M |
Comprehensive Income | 41.00K | -205.00K | 18.00K | 2.00K | 5.00K | -2.00K |
Shareholders Equity | 140.48M | 118.59M | 109.27M | 158.10M | -33.22M | -13.88M |
Total Investments | 154.00M | 94.95M | 88.48M | 131.86M | 15.53M | 7.20M |